A newly discovered gene combined with an already known genetic factor could explain the risk of skin side effects in more ...
RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking preclinical research that supports a nearly ...
A recent study discovered that a new gene test may assist predict which gout patients could suffer dangerous skin reactions ...
ProImmune has announced the launch of its ProVE SL Self-Loading MHC Class I Monomers, a new reagent platform designed to enhance antigen-specific CD8+ T cell detection. The Oxford-based life science ...
In a novel ABO-incompatible kidney transplantation, investigators converted the deceased donor kidney’s blood type.
ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility
ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility: Oxford, England Saturday, November 1, 2025, 14:00 Hrs [IST] ProImmune Ltd, a ...
A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...
The Irrawaddy highlights the junta-aligned candidates contesting Myanmar’s December polls, illustrated in a series of state ...
Dr. Kai Wang and his team published a review in Life Medicine to summarize the iPSC modification strategies to reach immune ...
Hansa Biopharma AB, "Hansa" today announced that it will host a virtual event featuring two distinguished transplant surgeons; Professor Robert Montgomery from NYU Langone Transplant Institute and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results